DUOTAP: Routine Postdilation May Optimize THV Geometry, Hemodynamics
Routine postdilation with a balloon-expandable transcatheter heart valve (THV) optimized THV geometry and improved hemodynamic performance, without increasing procedure-related adverse events in patients with severe aortic stenosis (AS), according to results from the DUOTAP trial presented at TCT 2026 and simultaneously published in JAMA Cardiology.
ENCIRCLE: Two-Year Results Following Transeptal TMVR in Patients With Severe MR
Patients with symptomatic mitral regurgitation (MR) who underwent full percutaneous transseptal transcatheter mitral valve replacement (TMVR) with the SAPIEN M3 system continued to see durable near MR elimination and sustained improvements in functional and health status outcomes at two years…
CLASP II TR: TTVr With PASCAL System Improves Health Status in Patients With Symptomatic Severe TR
Among patients with symptomatic severe tricuspid regurgitation (TR), transcatheter tricuspid valve repair (TTVr) with the PASCAL system in addition to optimal medical therapy (OMT) showed significant improvement in health status at one year when compared to OMT alone and no significant difference in mortality or heart failure (HF) hospitalization…
TomorrowLAND: Does Intracoronary Nicorandil Prevent No-Reflow in STEMI Patients Undergoing PCI?
Prolonged perfusion balloon predilation and intracoronary delivery of Nicorandil with the Rx Ryusei perfusion balloon did not significantly reduce slow-flow or no-reflow in patients presenting with STEMI undergoing primary PCI, according to findings from the TomorrowLAND trial presented at TCT 2026.
LIPSIA-STRATEGY: Angiography-Derived vs. Wire-Based FFR to Guide Revascularization
Angiography-derived vessel fractional flow reserve (vFFR)-guided revascularization met the prespecified absolute criterion for noninferiority to wire-based FFR, according to results from the LIPSIA-STRATEGY trial presented at TCT 2026 and simultaneously published in JACC.
SIRONA: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty at 3 Years
Comparing sirolimus-coated balloon (SCB) and paclitaxel-coated balloon (PCB) angioplasty in patients with symptomatic femoropopliteal artery disease, no differences in walking capacity and health-related quality of life were noted; however, freedom from clinically driven target-lesion revascularization (TLR) was higher in the SCB group, according to three-year results from the SIRONA trial, presented at TCT 2026 and simultaneously published in JACC: Cardiovascular Interventions.
SIMPLAAFY: Reduced-Dose NOACs, Aspirin Alone Noninferior to DAPT Following LAAC
Reduced-dose non-vitamin K oral anticoagulants (NOACs) as well as aspirin alone were noninferior to dual antiplatelet therapy (DAPT) for a composite of adverse clinical outcomes through six months following left atrial appendage closure (LAAC), according to results from the SIMPLAAFY trial…
Cost-Effectiveness of Early TAVR; TR and Mortality; Superiority of Tricuspid Repair
New late-breaking research presented at TCT 2026 highlights the cost-effectiveness of early TAVR in asymptomatic severe aortic stenosis (AS), the association between increasing tricuspid regurgitation (TR) severity and mortality, and the benefits of transcatheter tricuspid valve repair.
VERITAS and TRAVEL III: LAAO With Amulet 360; TTVR With LuX-Valve Plus System
Among patients who underwent left atrial appendage occlusion (LAAO) with the Amulet 360 device, complete LAA closure was observed in 96.3% of patients at one year with low rates of stroke and mortality, according to results from the VERITAS trial, presented at TCT 2026 and simultaneously published in JACC: Cardiovascular Interventions.
TECTONIC CAD and NODULE-SHOCK: IVL in Patients With Severely Calcified Lesions
Two separate studies presented at TCT 2026 and simultaneously published in JACC: Cardiovascular Interventions address the safety and effectiveness of intravascular lithotripsy (IVL) in patients with severely calcified lesions.
